Abstract:Studies in the area of human brain development are critical as research on neurological and psychiatric disorders has advanced, revealing the origins of pathophysiology to be in the earliest developmental stages. Only with a more precise understanding of the genes and environments that influence the brain in these early stages can we address questions about the pathology, diagnosis, prevention and treatment of neuropsychiatric disorders of developmental origin, like autism, schizophrenia, and Tourette syndrome. A new approach for studying early developmental events is the use of induced pluripotent stem cells (iPSCs). These are cells with wide potential, similar to that of embryonic stem cells, derived from mature somatic cells. We review the protocols used to create iPSCs, including the most efficient and reliable reprogramming strategies available to date for generating iPSCs. In addition, we discuss how this new tool can be applied to neuropsychiatric research. The use of iPSCs can advance our understanding of how genes and gene products are dynamically involved in the formation of unique features of the human brain, and how aberrant genetic variation may interfere with its typical formation. The iPSC technology, if properly applied, can also address basic questions about neural differentiation such as how stem cells can be guided into general and specific neurodevelopmental pathways. Current work in neuropsychiatry with iPSCs derived from patients has focused on disorders with specific genetics deficits and those with less-defined origins; it has revealed previously unknown aspects of pathology and potential pharmacological interventions. These exciting advances based on the use of iPSCs hold promise for improving early diagnosis and, possibly, treatment of psychiatric disorders. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'.

Using mouse transgenic and human stem cell technologies to model genetic mutations associated with schizophrenia and autism

Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges

Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders

Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development

Progress towards understanding risk factor mechanisms in the development of autism spectrum disorders

The power of human stem cell-based systems in the study of neurodevelopmental disorders

Developmental convergence and divergence in human stem cell models of autism spectrum disorder

Altered Axonal Targeting and Short-Term Plasticity in the Hippocampus of Disc1 Mutant Mice

Non-human Primate Models for Brain Disorders – Towards Genetic Manipulations Via Innovative Technology

Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies

Stem Cell Technology for (Epi)genetic Brain Disorders

From synapses to circuits: What mouse models have taught us about how autism spectrum disorder impacts hippocampal function

Translational neuroscience of schizophrenia: seeking a meeting of minds between mouse and man.

Human pluripotent stem cell (hPSC) and organoid models of autism: opportunities and limitations

Whole-brain in vivo base editing reverses autistic-like behaviors in mice

Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation

Modeling the complex genetic architectures of brain disease

In vivo models to study neurogenesis and associated neurodevelopmental disorders-Microcephaly and autism spectrum disorder

From cells to insights: the power of human pluripotent stem cell-derived cortical interneurons in psychiatric disorder modeling

Proximity analysis of native proteomes reveals phenotypic modifiers in a mouse model of autism and related neurodevelopmental conditions

Induction of core symptoms of autism spectrum disorder by in vivo CRISPR/Cas9-based gene editing in the brain of adolescent rhesus monkeys